The lethal ovitrap: A response to the resurgence of dengue and chikungunya
Autor(es): Zeichner Brian C, Debboun Mustapha
Resumo: There has been a global resurgence in dengue fever since the 1960s - now more than one third of the world's population lives in dengue endemic areas. Chikungunya, another mosquito-borne disease, had been limited to sub-Saharan Africa - Southeast Asia, but recently spread to Italy - France, raising concerns that it could spread to many more countries in Europe - the Americas. There are currently no vaccines available to prevent infection with either virus - medical care is limited to symptomatic - supportive treatments. Suppression of the mosquito vector populations reduces disease transmission, however, the tools currently available to control the main vectors of dengue - chikungunya are inadequate. Larval control is very labor intensive - pesticide sprays do not adequately penetrate the microhabitats where adult mosquitoes are sequestered. The lethal ovitrap addresses these shortcomings by luring the potentially viremic female mosquitoes to an egg laying site where they are exposed to a toxic insecticide dose. It is a safe, environmentally sound, economical, - simple means of dengue - chikungunya vector control whose efficacy has been documented in 9 research papers. Management programs using the lethal ovitrap have been shown to halt dengue - chikungunya transmission. Efforts are underway to mass produce the lethal ovitrap under the registered trade name Trap-N-Kill which will ensure its availability to our armed forces deployed in dengue - chikungunya endemic areas.
Imprenta: U.S. Army Medical Department Journal, p. 4-11, 2011
Descritores: Chikungunya virus - Pathogenesis ; Chikungunya virus - Viral infections ; Chikungunya Virus - Virus ; Chikungunya virus - Transmission ; Chikungunya virus - Vaccine ; Chikungunya virus - Chikungunya fever ; Chikungunya virus - Dengue ; Chikungunya virus - Public health
Data de publicação: 2011
